KYV-101 (Biological) - 0.33 ×10^8 cells
23-40657
Phase 1 mab active
Quick answer
KYV-101 (Biological) - 0.33 ×10^8 cells for Progressive Multiple Sclerosis is a Phase 1 program (mab) at Kyverna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kyverna Therapeutics
- Indication
- Progressive Multiple Sclerosis
- Phase
- Phase 1
- Modality
- mab
- Status
- active